Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
Malcikova J, Pavlova S, Kunt Vonkova B, Radova L, Plevova K, Kotaskova J, Pal K, Dvorackova B, Zenatova M, Hynst J, Ondrouskova E, Panovska A, Brychtova Y, Zavacka K, Tichy B, Tom N, Mayer J, Doubek M, Pospisilova S.
Malcikova J, et al. Among authors: tichy b.
Blood. 2021 Dec 23;138(25):2670-2685. doi: 10.1182/blood.2020009530.
Blood. 2021.
PMID: 33945616
Free PMC article.